Chengyong Liao

Artron Laboratories Inc.

Artron Laboratories Inc. was founded in 2002 by a team of dedicated and talented research scientists. Today, Artron has established itself as a global leader in the progression of in-vitro diagnostic lateral flow tests that have revolutionized the market for disease diagnosis and analyte detection. At Artron, we are devoted to excellence and innovation. Our mission is to overcome industry challenges and provide simple and affordable IVD products that meet your highest expectations. This is what our brand name means: Accurate Rapid Test with Response right On Needs. The combination of an experienced research team along with a highly developed production technology guarantees that our tests are of premium quality. Our extensive product catalogue includes lateral flow tests for the detection of fertility hormones, infectious diseases, tumor markers, cardiac markers, drugs of abuse, food safety, and genetically modified organisms. Not only do we have a wide range of products, we also have the necessary quality assurance and medical device licenses required for the worldwide distribution of our rapid test kits. Artron is an ISO 13485 certified company with products approved by FDA, Health Canada and CE. Our research and development facility located in Burnaby, British Columbia, is also compliant with Good Manufacturing Practices (GMP). It is fully equipped with advanced technology for operating in the fields of Molecular Biology, Monoclonal Antibody Development, Protein Purification and Rapid Test Kit Development. Artron also offers customization services. Our extremely capable design team utilizes advanced engineering techniques that enable us to customize products and tailor them to the individual needs of our clients. Our customization services include but are not limited to the development of custom-made lateral flow tests, monoclonal antibodies, critical membrane components, as well as OEM services.